Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Novel immune checkpoint blocker to treat Merkel cell carcinoma — Lorenzo Galluzzi (2017) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Novel immune checkpoint blocker to treat Merkel cell carcinoma
Shared by
Guido Guido Kroemer
Novel immune checkpoint blocker to treat Merkel cell carcinoma
Article
2017
en
Authors
LG
Lorenzo Galluzzi
Guido Guido Kroemer
Abstract
1 min read
Over the past few years, immune checkpoint blockers (ICBs) have literally revolutionized the treatment of multiple tumors, including (but not limited to) melanoma, non-small cell lung carcinoma (NS...
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2017
Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
Tuba N. Gide
,
James S. Wilmott
,
Richard A Scolyer
,
Georgina V. Long
Article
2022
Clinical, FDG-PET and Molecular Markers of Immune Checkpoint Inhibitor Response in Patients with Advanced Merkel Cell Carcinoma
Julia Dixon‐Douglas
,
Luke S. McLean
,
Alex Caneborg
,
Richard W. Tothill
,
Grace Kong
,
Rodney J. Hicks
,
Shahneen Sandhu
Article
2015
Immunotherapy of hematological cancers: PD-1 blockade for the treatment of Hodgkin's lymphoma
Guido Guido Kroemer
,
Lorenzo Galluzzi
Preprint
2023
Data from Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
Tuba N. Gide
,
James S. Wilmott
,
Richard A Scolyer
,
Georgina V. Long
Preprint
2023
Data from Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
Tuba N. Gide
,
James S. Wilmott
,
Richard A Scolyer
,
Georgina V. Long
Discussion(0)
No comments yet. Be the first to comment.